Development of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1) for cancer therapy: Identification of novel inhibitory fragments and modelling of binding to the active site.

Files in this item

Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics